Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Final Results of the Phase 3 SAFE Trial - Pharmacological Cardioprotective Strategy for Non-Metastatic Patients Affected by BC Receiving an Anthracycline-Based Chemo"
Comments 0
Login to view comments.
Click here to Login
